ReadingResearchRadarInvestment frameworkAI Company Primary Sources
Sign in / Sign up
← Back to reading
NewsQuick take3 min readDisconfirmAI Editorial

WRITER Study: AI Medical Q&A Almost Never Cites Pharmaceutical Company Content, Suggests Shifting Marketing Budget to Academic Publications

WRITER used its proprietary Agent tool to pose 40 medical queries to four major AI engines. An analysis of 777 cited sources revealed that 19.5% of answers directed at physicians came from academic journals, while commercial and manufacturer content was virtually invisible. Based on these findings, the article recommends that pharmaceutical companies redirect a portion of their digital marketing budgets toward increasing peer-reviewed publications, particularly by targeting mid-tier journals with shorter acceptance cycles.

2026-10-21 23:13 GMT+8

Product pages and display ads carefully optimized by pharmaceutical companies are almost entirely absent from AI medical Q&A systems. This is the core finding of a citation analysis released in October 2026 by WRITER. The study utilized the WRITER Agent tool to submit 40 health-related queries to four consumer-grade AI engines: Gemini/Google, ChatGPT, Perplexity, and Claude. These queries covered four therapeutic areas—oncology, obesity, immunology, and neurology—with half oriented toward patients and half toward physicians. All 777 cited sources were then categorized and sorted by type.

The results showed that when AI engines answered questions from physicians, 19.5% of citations originated from academic journals—a frequency four times higher than in patient-oriented queries. For physician-facing responses, the most frequently cited domain was PubMed/PMC (cited 50 times), whereas for patients, it was GoodRx (cited 15 times). The only domain appearing in both top lists was fda.gov. Commercial and manufacturer content remained virtually invisible across both query types. WRITER summarized this pattern as follows: AI search synthesizes medical answers from high-trust third-party sources such as academic literature, institutional websites, and reference platforms, while deprioritizing commercial and manufacturer content.

Based on this discovery, WRITER proposed strategic recommendations for pharmaceutical companies: shift a portion of digital marketing budgets away from traditional SEO, display advertising, and sponsored content toward evidence generation, specifically by increasing the volume of peer-reviewed publications. The article emphasizes the importance of publication volume—when an AI engine synthesizes answers from hundreds of sources, having only a dozen papers in a therapeutic area will not attract attention. WRITER recommends a journal portfolio strategy: continue targeting top-tier journals such as The New England Journal of Medicine, The Lancet, and JAMA, while simultaneously submitting to mid-tier journals with shorter acceptance cycles to accelerate the indexing of content. Conference abstracts and posters, which are also indexed in PubMed, can serve as additional citable content sources.

Sign in / Sign up
ReadingResearchRadarInvestment frameworkAI Company Primary Sources

WRITER also recommended using AI-assisted writing to expand publication capacity, arguing that manual medical writing teams cannot produce the volume of publications required to influence AI-generated answers. The article acknowledges that peer-reviewed research has explicitly listed the risks associated with AI participation in writing—including hallucinated references, bias amplification, and exposure of confidentiality—but cites the same body of research confirming that AI can accelerate manuscript preparation in stages such as literature discovery, citation validation, and editorial refinement, provided human experts remain involved at every stage.

It is important to note that this study has significant limitations. The sample size of 40 queries is small, the full methodology is marked as available upon request but not publicly disclosed, and WRITER itself is a commercial supplier of AI writing tools; thus, its recommendation that AI is necessary to publish at this scale aligns directly with its own product positioning. The article cites research from DataForSEO as independent corroboration, noting that health content is particularly suitable for citation and that large language models tend to favor medically authoritative sources such as the CDC, Mayo Clinic, and peer-reviewed publications. However, DataForSEO’s specific methods and sample sizes are not detailed in this article. The core mechanistic finding—that AI engines prefer academic and institutional sources while deprioritizing commercial content—is consistent with broader discussions on AI search visibility. WRITER’s contribution lies in providing specialized data for the healthcare sector and concrete operational pathways for medical affairs teams.

Sources

  • writer.comWRITER↗
Continue researching →